New injection aims to fix lung and liver protein deficiency
Disease control
Recruiting now
This early-stage study tests a new drug called AIR-001 in 54 adults with Alpha-1 Antitrypsin Deficiency (AATD) who have the PiZZ genetic type. The goal is to see if the drug is safe and can raise levels of a protective protein that is missing in these patients. Participants recei…
Phase: PHASE1 • Sponsor: AIRNA Corporation • Aim: Disease control
Last updated May 13, 2026 16:04 UTC